Home
XRTX
XRTX News

Latest XORTX Therapeutics Inc. (XRTX) News on June 8, 2025

XORTX Announces USD $3 Million Offering

GlobeNewswire

20 days ago

XORTX Announces USD $3 Million Offering

XORTX Provides Update on FDA Type B Meeting Request

GlobeNewswire

a month ago

XORTX Provides Update on FDA Type B Meeting Request

XORTX Announces Grant of European Patent

GlobeNewswire

a month ago

XORTX Announces Grant of European Patent

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

GlobeNewswire

2 months ago

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

XORTX Announces Update for Discussion with the FDA

GlobeNewswire

3 months ago

XORTX Announces Update for Discussion with the FDA

XORTX Commences Gout Program NDA Discussions with the FDA

GlobeNewswire

3 months ago

XORTX Commences Gout Program NDA Discussions with the FDA

XORTX to Present at Microcap Conference

GlobeNewswire

4 months ago

XORTX to Present at Microcap Conference

XORTX Announces Change of Auditor

GlobeNewswire

5 months ago

XORTX Announces Change of Auditor

XORTX Adds Late Stage Gout Program to Pipeline

GlobeNewswire

5 months ago

XORTX Adds Late Stage Gout Program to Pipeline

XORTX Strengthens Executive Team

GlobeNewswire

6 months ago

XORTX Strengthens Executive Team

XORTX Announces Presentation at the Rare and Genetic Disease Summit

GlobeNewswire

6 months ago

XORTX Announces Presentation at the Rare and Genetic Disease Summit

XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024

GlobeNewswire

7 months ago

XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

GlobeNewswire

8 months ago

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

GlobeNewswire

8 months ago

XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XORTX Initiates Precision Medicine Program

GlobeNewswire

8 months ago

XORTX Initiates Precision Medicine Program

XORTX Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire

9 months ago

XORTX Announces Results of Annual and Special Meeting of Shareholders

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

GlobeNewswire

9 months ago

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

GlobeNewswire

9 months ago

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

GlobeNewswire

9 months ago

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism

GlobeNewswire

9 months ago

XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

GlobeNewswire

10 months ago

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

GlobeNewswire

10 months ago

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

XORTX to Present at BIO International Convention 2024

GlobeNewswire

a year ago

XORTX to Present at BIO International Convention 2024

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

GlobeNewswire

a year ago

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

GlobeNewswire

a year ago

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

XORTX Announces Publication of Key Research in ADPKD

GlobeNewswire

a year ago

XORTX Announces Publication of Key Research in ADPKD

XORTX Welcomes New Member to the Board of Directors

GlobeNewswire

a year ago

XORTX Welcomes New Member to the Board of Directors

XORTX Announces Participation in Spring 2024 Investor Conferences

GlobeNewswire

a year ago

XORTX Announces Participation in Spring 2024 Investor Conferences

XORTX Announces New Clinical Advisory Board Member

GlobeNewswire

a year ago

XORTX Announces New Clinical Advisory Board Member

XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial

News Direct

a year ago

XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

GlobeNewswire

a year ago

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

GlobeNewswire

a year ago

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

GlobeNewswire

a year ago

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of Units

GlobeNewswire

a year ago

XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of Units

GlobeNewswire

a year ago

XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units

Celularity and Genting Leaders Comments on Closing $21 Million Financing Transactions

GlobeNewswire

a year ago

Celularity and Genting Leaders Comments on Closing $21 Million Financing Transactions

Interactive Strength, Inc. d/b/a FORME (Nasdaq: TRNR) Amends Terms of CLMBR Acquisition and Expects to Close in January 2024, Creating a High-growth, B2B Focused, Connected Fitness Platform

NewMediaWire

a year ago

Interactive Strength, Inc. d/b/a FORME (Nasdaq: TRNR) Amends Terms of CLMBR Acquisition and Expects to Close in January 2024, Creating a High-growth, B2B Focused, Connected Fitness Platform

ACCESSWIRE

a year ago

Vision Marine Technologies Inc. Announces Close of $3.0 Million Private Placement of Convertible Preferred Shares and Warrants with Investissement Québec

Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada

PR Newswire

a year ago

Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada

Vision Marine Technologies Inc. (VMAR) Reports Q1 Loss, Misses Revenue Estimates

Zacks

a year ago

Vision Marine Technologies Inc. (VMAR) Reports Q1 Loss, Misses Revenue Estimates

XORTX Announces $2 Million Public Offering

GlobeNewswire

a year ago

XORTX Announces $2 Million Public Offering

Educational Development Corporation (NASDAQ:EDUC) Q3 2024 Earnings Call Transcript

Insider Monkey

a year ago

Educational Development Corporation (NASDAQ:EDUC) Q3 2024 Earnings Call Transcript

Vision Marine Technologies Inc. Closes Strategic Investment from the Government of Quebec, Through Investissement Quebec

ACCESSWIRE

a year ago

Vision Marine Technologies Inc. Closes Strategic Investment from the Government of Quebec, Through Investissement Quebec

PodcastOne (NASDAQ: PODC) Continues to Expand Its Award Winning Slate With the Launch of Varnamtown Podcast

GlobeNewswire

a year ago

PodcastOne (NASDAQ: PODC) Continues to Expand Its Award Winning Slate With the Launch of Varnamtown Podcast

Sadot Group Inc. Announces New Trading Arm - Sadot Brasil Ltda

ACCESSWIRE

a year ago

Sadot Group Inc. Announces New Trading Arm - Sadot Brasil Ltda

Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

a year ago

Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results

Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2024

Business Wire

a year ago

Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2024

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

GlobeNewswire

a year ago

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

XORTX Welcomes New Member to the Board of Directors

GlobeNewswire

a year ago

XORTX Welcomes New Member to the Board of Directors

Analysts Expect Breakeven For Hall of Fame Resort & Entertainment Company (NASDAQ:HOFV) Before Long

Simply Wall St.

a year ago

Analysts Expect Breakeven For Hall of Fame Resort & Entertainment Company (NASDAQ:HOFV) Before Long

Hall of Fame Resort & Entertainment Company Partners with Josh Harris and David Blitzer to Elevate Youth Sports at Hall of Fame Village

PR Newswire

a year ago

Hall of Fame Resort & Entertainment Company Partners with Josh Harris and David Blitzer to Elevate Youth Sports at Hall of Fame Village

Leju Announces Receipt of NYSE Non-Compliance Letter

PR Newswire

a year ago

Leju Announces Receipt of NYSE Non-Compliance Letter

SELLAS Receives FDA Orphan Drug Designation for SLS009 for Treatment of Peripheral T-cell Lymphomas

GlobeNewswire

a year ago

SELLAS Receives FDA Orphan Drug Designation for SLS009 for Treatment of Peripheral T-cell Lymphomas

Thomson Reuters StreetEvents

a year ago

Q4 2023 Optical Cable Corp Earnings Call

OPTICAL CABLE CORPORATION REPORTS FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS

PR Newswire

a year ago

OPTICAL CABLE CORPORATION REPORTS FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS

OPTICAL CABLE CORPORATION SCHEDULES CONFERENCE CALL TO DISCUSS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS

PR Newswire

a year ago

OPTICAL CABLE CORPORATION SCHEDULES CONFERENCE CALL TO DISCUSS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS

Vista Gold Corp. Announces Receipt of the $3 Million First Installment Payment Under Wheaton Precious Metals Royalty

Business Wire

a year ago

Vista Gold Corp. Announces Receipt of the $3 Million First Installment Payment Under Wheaton Precious Metals Royalty

Vision Marine Technologies Inc. Announces $3.0 Million Private Placement of Convertible Preferred Shares and Warrants

ACCESSWIRE

a year ago

Vision Marine Technologies Inc. Announces $3.0 Million Private Placement of Convertible Preferred Shares and Warrants

IBN Announces Latest Episode of The Bell2Bell Podcast featuring Bruce Nurse, Head of Investor Relations for Vision Marine Technologies Inc.

GlobeNewswire

a year ago

IBN Announces Latest Episode of The Bell2Bell Podcast featuring Bruce Nurse, Head of Investor Relations for Vision Marine Technologies Inc.

Locafy Announces First Subscription Contract from Agreement with U.S.-Based Media Publisher

GlobeNewswire

a year ago

Locafy Announces First Subscription Contract from Agreement with U.S.-Based Media Publisher

Apollomics Presents Data from Phase 2 Clinical Trials of Lung Cancer Medication

Exec Edge

2 years ago

Apollomics Presents Data from Phase 2 Clinical Trials of Lung Cancer Medication

IZEA Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

GlobeNewswire

2 years ago

IZEA Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

Vision Marine Technologies Initiates First E-Motion(TM) Equipped Rental Operation Expansion in Florida in Partnership with Blue Water Boat Rental

ACCESSWIRE

2 years ago

Vision Marine Technologies Initiates First E-Motion(TM) Equipped Rental Operation Expansion in Florida in Partnership with Blue Water Boat Rental

Estimating The Intrinsic Value Of CISO Global Inc. (NASDAQ:CISO)

Simply Wall St.

2 years ago

Estimating The Intrinsic Value Of CISO Global Inc. (NASDAQ:CISO)

Gain Therapeutics Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Allosteric Regulators in GM1 Gangliosidosis Model

GlobeNewswire

2 years ago

Gain Therapeutics Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Allosteric Regulators in GM1 Gangliosidosis Model

XORTX Announces US ATM Offering

GlobeNewswire

2 years ago

XORTX Announces US ATM Offering

Pension Benefit Guaranty Corporation Renews Comprehensive Risk Management Services Contract with CISO Global

GlobeNewswire

2 years ago

Pension Benefit Guaranty Corporation Renews Comprehensive Risk Management Services Contract with CISO Global

XORTX Meets Nasdaq Continued Listing Requirements

GlobeNewswire

2 years ago

XORTX Meets Nasdaq Continued Listing Requirements

11 Cheapest Stocks With Biggest Upside

Insider Monkey

2 years ago

11 Cheapest Stocks With Biggest Upside

3 Electric Boat Stocks That Will Sail Higher by 2024

InvestorPlace

2 years ago

3 Electric Boat Stocks That Will Sail Higher by 2024

Flexible Solutions International, Inc. (AMEX:FSI) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Flexible Solutions International, Inc. (AMEX:FSI) Q3 2023 Earnings Call Transcript

Vision Marine Technologies: Pioneering Electric Propulsion with Innovative Pontoon Integration

ACCESSWIRE

2 years ago

Vision Marine Technologies: Pioneering Electric Propulsion with Innovative Pontoon Integration

NeurAxis Announces CareFirst BCBS Policy Coverage

GlobeNewswire

2 years ago

NeurAxis Announces CareFirst BCBS Policy Coverage

Hudson RPO Appoints Jake Zabkowicz as Global CEO

GlobeNewswire

2 years ago

Hudson RPO Appoints Jake Zabkowicz as Global CEO

Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives

GlobeNewswire

2 years ago

Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2023 Earnings Call Transcript

XORTX Clarifies Timing for Share Consolidation

GlobeNewswire

2 years ago

XORTX Clarifies Timing for Share Consolidation

Associated Press Finance

2 years ago

Team: Q3 Earnings Snapshot

Team, Inc. Reports Third Quarter 2023 Results

GlobeNewswire

2 years ago

Team, Inc. Reports Third Quarter 2023 Results

XORTX Announces Share Consolidation

GlobeNewswire

2 years ago

XORTX Announces Share Consolidation

TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Third Quarter 2023 Financial Results on November 14, 2023

GlobeNewswire

2 years ago

TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Third Quarter 2023 Financial Results on November 14, 2023

Associated Press Finance

2 years ago

Trinseo: Q3 Earnings Snapshot

Li-Cycle Adopts Limited Duration Shareholder Rights Plan

Business Wire

2 years ago

Li-Cycle Adopts Limited Duration Shareholder Rights Plan

Share on Social Networks: